GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Keap1 | decreases expression | EXP | | 6480464 | CTD | Arsenic Trioxide results in decreased expression of KEAP1 protein | PMID:24634002 PMID:32920515 | Keap1 | increases expression | EXP | | 6480464 | CTD | Arsenic Trioxide results in increased expression of KEAP1 mRNA | PMID:29223816 | Keap1 | multiple interactions | EXP | | 6480464 | CTD | crocin inhibits the reaction [Arsenic Trioxide results in decreased expression of KEAP1 protein] | PMID:32920515 | Keap1 | affects response to substance | ISO | KEAP1 (Homo sapiens) | 6480464 | CTD | KEAP1 gene mutant form affects the susceptibility to Arsenic Trioxide | PMID:30815697 | Keap1 | decreases response to substance | ISO | KEAP1 (Homo sapiens) | 6480464 | CTD | KEAP1 protein results in decreased susceptibility to Arsenic Trioxide | PMID:22684020 | Keap1 | increases expression | ISO | KEAP1 (Homo sapiens) | 6480464 | CTD | Arsenic Trioxide results in increased expression of KEAP1 mRNA; Arsenic Trioxide results in increased expression of KEAP1 protein | PMID:15894607 PMID:19417148 PMID:22684020 | Keap1 | increases expression | ISO | Keap1 (Mus musculus) | 6480464 | CTD | Arsenic Trioxide results in increased expression of KEAP1 protein | PMID:33846815 | Keap1 | increases response to substance | ISO | KEAP1 (Homo sapiens) | 6480464 | CTD | KEAP1 mRNA results in increased susceptibility to Arsenic Trioxide | PMID:26708503 | Keap1 | multiple interactions | ISO | KEAP1 (Homo sapiens) | 6480464 | CTD | [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of KEAP1 mRNA; Arsenic Trioxide affects the reaction [KEAP1 protein results in increased expression of CCND1 protein]; KEAP1 mRNA inhibits the reaction [Ethionamide results in increased susceptibility to Arsenic Trioxide]; KEAP1 protein inhibits the reaction [Arsenic Trioxide results in decreased expression of CCND1 mRNA]; KEAP1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of PPARG mRNA]; KEAP1 protein inhibits the reaction [Arsenic Trioxide results in increased expression of PPARG protein]; KEAP1 protein promotes the reaction [Rosiglitazone results in increased susceptibility to Arsenic Trioxide]; KEAP1 protein promotes the reaction [Troglitazone results in increased susceptibility to Arsenic Trioxide]; NFE2L2 protein promotes the reaction [Arsenic Trioxide results in increased expression of KEAP1 protein] | PMID:15894607 PMID:22684020 PMID:26708503 | Keap1 | multiple interactions | ISO | Keap1 (Mus musculus) | 6480464 | CTD | 18alpha,20beta-hydroxy-11-oxo-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranurosyl-alpha-D-glucopyranosiduronate magnesium tetrahydrate inhibits the reaction [Arsenic Trioxide results in increased expression of KEAP1 protein] | PMID:33846815 | |
Go Back to source page | Continue to Ontology report |